Latest filing published 23 May 2025 for Tandem Diabetes Care INC, €80k.
Filing timeline
BuySaleInsider track record
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Kathleen McGroddy-Goetz: trading record in brief
All filings by Kathleen McGroddy-Goetz on record concern Tandem Diabetes Care Inc, in the capacity of board member. Over a trading history stretching from 8 June 2021 to 22 May 2025, the count stands at 9 filings.
On the open market, the record shows 1 purchase worth €20k and 1 sale worth €39k. Taken together, the sales exceed the purchases by €19k. Unlike grants, an open-market purchase is paid for by the insider, at the market price. Other entries cover 7 option exercises.
On 23 May 2025 came the latest disclosure, an option exercise for €80k in Tandem Diabetes Care Inc. The last purchase on record was published on 19 September 2023, which is 1,148 days ago. The median gap between a trade and its publication by SEC (Form 4) is 2 days. Section 16 rules allow two business days to file each Form 4. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Kathleen McGroddy-Goetz
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 4,387 shares@ US$20.6422.8% of flowCommon StockSEC:0001438133-25-000108:0
- 4,434 shares@ US$51.7360.3% of flowCommon StockSEC:0001438133-24-000124:0
- 1,000 shares@ US$21.4533.9% of flowCommon StockSEC:0001438133-23-000197:0Canonical exit: 14 Dec 2023 (T+90)
- 1,220 shares0Common StockSEC:0001438133-23-000135:0
- 2,757 shares0Common StockSEC:0001438133-23-000107:0
- 1,220 shares0Common StockSEC:0001438133-22-000158:0
- 2,021 shares0Common StockSEC:0001438133-22-000099:0
- 405 shares@ US$106.0011.2% of flowCommon StockSEC:0001438133-22-000039:0
- 1,219 shares0Common StockSEC:0001438133-21-000095:0
9 of 9 declarations
